• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小关节挛缩的存在是439例系统性硬化症患者生存的一个风险因素。

The presence of small joint contractures is a risk factor for survival in 439 patients with systemic sclerosis.

作者信息

Nagy Gabriella, Minier Tünde, Varjú Cecília, Faludi Réka, Kovács Katalin T, Lóránd Veronika, Hermann Veronika, Czirják László, Kumánovics Gábor

机构信息

Department of Rheumatology and Immunology, University of Pécs, Hungary.

Heart Institute, Medical Center University of Pécs, Hungary.

出版信息

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):61-70. Epub 2017 Aug 31.

PMID:28869411
Abstract

OBJECTIVES

Analysis of risk factors and mortality of 439 patients with systemic sclerosis (SSc) in a tertiary care centre.

METHODS

The mean follow up time was 8.4±5.6 years. Lost to follow up rate was 6.4%. Female to male ratio was 366 to 73. Two hundred sixty patients had limited and 179 diffuse cutaneous SSc (dcSSc). A standard protocol including musculoskeletal examinations was used for the assessment of patients.

RESULTS

By Kaplan-Meier analysis the overall 5-, 10- and 15 year survival were 88.2%, 79.9% and 73.6%, respectively. Univariate analysis showed that dcSSc, male gender, presence of small joint contractures, pulmonary interstitial, cardiac, oesophageal involvement, scleroderma renal crisis, arterial hypertension, anti-topoisomerase antibody, anemia, hypalbuminemia, coexistent malignancies and elevated erythrocyte sedimentation were associated with poor survival. Lack of giant capillaries, avascular zones or neo-angiogenesis on capillaroscopy, and presence of anti-centromere antibodies were associated with favourable outcome. Multivariate regression analysis showed presence of small joint contractures, history of arterial hypertension, male gender, diffusing capacity of carbon monoxide <50%, right ventricular pressure >40 mmHg on echocardiography, less than 50% ejection fraction, anti-topoisomerase I positivity, anemia, and serum albumin concentration < 35 g/l as well as current or history of coexistent malignancy were independent poor prognostic factors.

CONCLUSIONS

In addition to well-known factors predicting poor outcome in SSc, the presence of small joint contractures was a newly identi ed independent risk factor of mortality. Our data also confirmed a recent finding showing that history of arterial hypertension was also a poor prognostic factor.

摘要

目的

分析一家三级医疗中心439例系统性硬化症(SSc)患者的危险因素及死亡率。

方法

平均随访时间为8.4±5.6年。失访率为6.4%。男女比例为366比73。260例患者为局限性皮肤型SSc,179例为弥漫性皮肤型SSc(dcSSc)。采用包括肌肉骨骼检查在内的标准方案对患者进行评估。

结果

通过Kaplan-Meier分析,总体5年、10年和15年生存率分别为88.2%、79.9%和73.6%。单因素分析显示,dcSSc、男性、小关节挛缩、肺间质病变、心脏病变、食管受累、硬皮病肾危象、动脉高血压、抗拓扑异构酶抗体、贫血、低白蛋白血症、并存恶性肿瘤以及红细胞沉降率升高与生存率低相关。毛细血管镜检查显示缺乏巨大毛细血管、无血管区或新生血管形成,以及存在抗着丝点抗体与良好预后相关。多因素回归分析显示,小关节挛缩、动脉高血压病史、男性、一氧化碳弥散量<50%、超声心动图显示右心室压力>40 mmHg、射血分数<50%、抗拓扑异构酶I阳性、贫血、血清白蛋白浓度<35 g/l以及并存恶性肿瘤的现患或既往史是独立的不良预后因素。

结论

除了已知的预测SSc不良预后的因素外,小关节挛缩的存在是新发现的独立死亡危险因素。我们的数据还证实了最近的一项发现,即动脉高血压病史也是不良预后因素。

相似文献

1
The presence of small joint contractures is a risk factor for survival in 439 patients with systemic sclerosis.小关节挛缩的存在是439例系统性硬化症患者生存的一个风险因素。
Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):61-70. Epub 2017 Aug 31.
2
Determinants of morbidity and mortality of systemic sclerosis in Canada.加拿大系统性硬化症发病率和死亡率的决定因素。
Semin Arthritis Rheum. 2010 Feb;39(4):269-77. doi: 10.1016/j.semarthrit.2008.06.002. Epub 2008 Aug 15.
3
A three-year follow-up study of the development of joint contractures in 131 patients with systemic sclerosis.一项对131例系统性硬化症患者关节挛缩发展情况的三年随访研究。
Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-68-74. Epub 2014 Aug 4.
4
Prediction of pulmonary complications and long-term survival in systemic sclerosis.系统性硬化症肺部并发症及长期生存预测。
Arthritis Rheumatol. 2014 Jun;66(6):1625-35. doi: 10.1002/art.38390.
5
Survival and causes of death in 366 Hungarian patients with systemic sclerosis.366例匈牙利系统性硬化症患者的生存情况及死因
Ann Rheum Dis. 2008 Jan;67(1):59-63. doi: 10.1136/ard.2006.066340. Epub 2007 May 22.
6
Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.在西班牙系统性硬化症患者中与死亡率相关的生存、死因和危险因素:来自一家大学医院的结果。
Semin Arthritis Rheum. 2010 Feb;39(4):285-93. doi: 10.1016/j.semarthrit.2009.06.002. Epub 2009 Sep 25.
7
Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.西班牙系统性硬皮病网络注册研究:根据皮肤亚型和免疫状态的临床表现。
Semin Arthritis Rheum. 2012 Jun;41(6):789-800. doi: 10.1016/j.semarthrit.2011.10.004. Epub 2011 Dec 12.
8
Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.西班牙系统性硬化症患者队列中抗体谱对临床特征和预后的影响。
Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):98-105. Epub 2017 Sep 21.
9
Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.跳出固有思维——系统性硬化症的皮肤受累与自身抗体状态之间的关联并不总是我们所预期的那样。
Semin Arthritis Rheum. 2015 Oct;45(2):184-9. doi: 10.1016/j.semarthrit.2015.04.009. Epub 2015 Apr 10.
10
Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.系统性硬化症伴弥漫性皮肤受累中的孤立性肺动脉高压:与血清抗U3RNP抗体的关联
J Rheumatol. 1996 Apr;23(4):639-42.

引用本文的文献

1
Patient-reported gastrointestinal involvement is associated with reduced quality of life and disability in systemic sclerosis.患者报告的胃肠道受累与系统性硬化症患者生活质量下降和残疾相关。
J Scleroderma Relat Disord. 2025 Jun 5:23971983251345284. doi: 10.1177/23971983251345284.
2
Microstomia is associated with functional impairment and is a poor prognostic factor in systemic sclerosis - a single center observational study with survival analysis.小口畸形与功能障碍相关,并且是系统性硬化症的预后不良因素——一项带有生存分析的单中心观察性研究。
BMC Oral Health. 2024 Nov 15;24(1):1390. doi: 10.1186/s12903-024-05178-6.
3
Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis.
硬皮病患者的 ScleroID 特征强调了肌肉骨骼和内脏器官的影响。
Arthritis Res Ther. 2023 May 20;25(1):84. doi: 10.1186/s13075-023-03063-1.
4
Minimal Clinically Important Differences (MCID) for the Functional Assessment of Chronic Illness Therapy Fatigue Scale in Patients with Systemic Sclerosis.系统性硬化症患者慢性疾病治疗疲劳量表功能评估的最小临床重要差异(MCID)。
Int J Environ Res Public Health. 2022 Dec 31;20(1):771. doi: 10.3390/ijerph20010771.
5
Inflammatory arthritis in systemic sclerosis: What to do?系统性硬化症中的炎性关节炎:该如何应对?
J Scleroderma Relat Disord. 2019 Feb;4(1):3-16. doi: 10.1177/2397198318779532. Epub 2018 Jun 19.